Pitt Public Health Students

Prepare to Change the World

The University of Pittsburgh Graduate School of Public Health is a
top-ranked, internationally respected center of learning and research
that prepares students to influence public health practices and
medical care across the country and around the world.

Learn more                   Coronavirus response

 

COVID Cases Still Low in Allegheny County, While Opioid Overdoses Continue to Plague Residents

WESA-FM - "[That's] a big loo...
COVID Cases Still Low in Allegheny County, While Opioid Overdoses Continue to Plague Residents

WESA-FM - "[That's] a big loophole there in terms of potentially not having people covered who are sick," said board chair IDM and EPI's Lee Harrison.  (07/23/2021)

Mellors: COVID-19 Immune Response Could be Long Lasting, but Variants Present Risks

THE WALL STREET JOURNAL - Stu...
Mellors: COVID-19 Immune Response Could be Long Lasting, but Variants Present Risks

THE WALL STREET JOURNAL - Studies show that variants including Delta can partially evade immune response from infection and vaccination. "Give the virus time and opportunity, we don't know what will arise," said IDM's John Mellors chief of infectious diseases at UPMC.  (07/23/2021)

Nace among those saying we should require COVID-19 vaccination of all health care workers

PITTSBURGH POST-GAZETTE - "I'...
Nace among those saying we should require COVID-19 vaccination of all health care workers

PITTSBURGH POST-GAZETTE - "I'm hopeful that this will help to start improving the vaccine uptake among employees in the long-term care workforce, because we really need to get those numbers up," said David Nace (EPI '95), chief medical officer of UPMC Senior Communities and an expert in long-term c... (07/23/2021)

Donohue finds more Americans are receiving addiction treatment, but gaps persist

PITTWIRE - Substantially more...
Donohue finds more Americans are receiving addiction treatment, but gaps persist

PITTWIRE - Substantially more people in the U.S. with opiiod use disorder are receiving evidence-based treatment for the disease, but there are still considerable gaps in care along racial lines, according to the largest analysis to date of opioid use disorder among Medicaid recipients. The results... (07/23/2021)

Donohue study says Opioid Use Disorder Treatment Rises in Medicaid Recipients

MEDPAGE TODAY - The proportio...
Donohue study says Opioid Use Disorder Treatment Rises in Medicaid Recipients

MEDPAGE TODAY - The proportion of people with opioid use disorder who received buprenorphine (Buprenex), methadone, or naltrexone (Revia) increased from 47.8% to 57.1% in an exploratory serial cross-sectional study by HPM Chair Julie Donohue and colleagues.  (07/23/2021)